Skip to main content

Table 7 Adverse event rates (%)

From: Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison

Adverse events a

OLAI

RLAI

Weight gain

9.0

6.0

Extra-pyramidal symptoms

15.0

25.0

Tardive dyskinesia

0.0

0.0

Somnolence

7.0

5.0

Sexual dysfunction

3.0

3.0

Post-injection syndrome

2.0

0.0

Suicide

0.0

0.0

  1. aAdverse event rates were taken from [14],[40],[48].
Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us